{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:56:31Z","timestamp":1784944591111,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ebiom.2026.106212","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:32:01Z","timestamp":1773743521000},"page":"106212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-term impact of SARS-CoV-2 on recurrent COPD exacerbations"],"prefix":"10.1016","volume":"126","author":[{"given":"Sonya S.","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-2827","authenticated-orcid":false,"given":"Tim Q.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9589","key":"10.1016\/j.ebiom.2026.106212_bib1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106212_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","article-title":"Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality","volume":"67","author":"Suissa","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.ebiom.2026.106212_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3389\/fimmu.2020.01205","article-title":"Mechanisms of virus-induced airway immunity dysfunction in the pathogenesis of COPD disease, progression, and exacerbation","volume":"11","author":"Guo-Parke","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106212_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113791","article-title":"The complex association between COPD and COVID-19","volume":"12","author":"Awatade","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106212_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis","volume":"15","author":"Alqahtani","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106212_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105941","article-title":"Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)","volume":"167","author":"Lippi","year":"2020","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12013-024-01529-w","article-title":"Understanding the impact of SARS-CoV-2 on lung endothelial cells: brief mechanisms unveiled","volume":"83","author":"Shah","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.ebiom.2026.106212_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155618","article-title":"Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19","volume":"148","author":"Hasegawa","year":"2021","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106212_bib9","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.4049\/jimmunol.1800671","article-title":"Influenza A virus infection causes chronic lung disease linked to sites of active viral RNA remnants","volume":"201","author":"Keeler","year":"2018","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-021-03159-9","article-title":"Virus infection induced pulmonary fibrosis","volume":"19","author":"Huang","year":"2021","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106212_bib11","article-title":"Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis","volume":"52","author":"Ahmed","year":"2020","journal-title":"J Rehabil Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106212_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00056-2022","article-title":"Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis","volume":"8","author":"Huntley","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ebiom.2026.106212_bib13","article-title":"Outcomes of hospitalized patients with COVID-19 with acute kidney injury and acute cardiac injury","volume":"8","author":"Lu","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22741-9","article-title":"Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge","volume":"12","author":"Lu","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106212_bib15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ejh.14058","article-title":"Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: a 2.5-year follow-up study","volume":"111","author":"Feit","year":"2023","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib16","article-title":"COVID-19 patients in the COVID-19 recovery and engagement (CORE) clinics in the Bronx","volume":"13","author":"Eligulashvili","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106212_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15277","article-title":"Characteristics of COVID-19 patients with multiorgan injury across the pandemic in a large academic health system in the Bronx, New York","volume":"9","author":"Lu","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106212_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004263","article-title":"Long-term outcomes of hospitalized patients with SARS-CoV-2\/COVID-19 with and without neurological involvement: 3-year follow-up assessment","volume":"21","author":"Eligulashvili","year":"2024","journal-title":"PLoS Med"},{"key":"10.1016\/j.ebiom.2026.106212_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123477","article-title":"Long-Term Outcomes of Patients with a Pre-Existing Neurological Condition After SARS-CoV-2 Infection","volume":"473","author":"Hadidchi","year":"2025","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebiom.2026.106212_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105613","article-title":"SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population","volume":"86","author":"Hadidchi","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106212_bib21","article-title":"Long-term outcomes of patients with pre-existing essential tremor after SARS-CoV-2 infection","volume":"14","author":"Pakan","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106212_bib22","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/ndt\/gfad020","article-title":"Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI","volume":"38","author":"Lu","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106212_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1378\/chest.128.3.1393","article-title":"1-year pulmonary function and health status in survivors of severe acute respiratory syndrome","volume":"128","author":"Ong","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01612-2023","article-title":"Long-term radiological and pulmonary function abnormalities at 3 years after COVID-19 hospitalisation: a longitudinal cohort study","volume":"64","author":"Han","year":"2024","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106212_bib27","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106212_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cair.2006.02.001","article-title":"Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion","volume":"6","author":"Tesfaigzi","year":"2006","journal-title":"Clin Appl Immunol Rev"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106212_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12931-025-03123-x","article-title":"Risk of acute exacerbation of chronic obstructive pulmonary disease after COVID-19 recovery: a nationwide population-based cohort study","volume":"26","author":"Kim","year":"2025","journal-title":"Respir Res"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106212_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/01410768231184162","article-title":"Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults","volume":"116","author":"Hyams","year":"2023","journal-title":"J R Soc Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106212_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-112376","article-title":"Recurrent COVID-19 infection and the risk of exacerbation, mortality and long covid in patients with chronic obstructive pulmonary disease: a nationwide retrospective cohort study","volume":"16","author":"Lee","year":"2026","journal-title":"BMJ Open"},{"issue":"151","key":"10.1016\/j.ebiom.2026.106212_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0063-2018","article-title":"Respiratory viral infection: a potential \"missing link\" in the pathogenesis of COPD","volume":"28","author":"Linden","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106212_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cnm.3707","article-title":"Airway obstruction in respiratory viral infections due to impaired mucociliary clearance","volume":"39","author":"Bessonov","year":"2023","journal-title":"Int J Numer Method Biomed Eng"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106212_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/jech-2020-214401","article-title":"The COVID-19 pandemic and health inequalities","volume":"74","author":"Bambra","year":"2020","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106212_bib37","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-1501","article-title":"Inequities during COVID-19","volume":"146","author":"Ambrose","year":"2020","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106212_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2213-2600(20)30234-4","article-title":"COVID-19 and the impact of social determinants of health","volume":"8","author":"Abrams","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2026.106212_bib39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fpubh.2020.00406","article-title":"Impact of social determinants of health on the emerging COVID-19 pandemic in the United States","volume":"8","author":"Singu","year":"2020","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106212_bib40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1378\/chest.10-2869","article-title":"Racial differences in quality of life in patients with COPD","volume":"140","author":"Han","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106212_bib41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/rccm.202009-3721OC","article-title":"Racial segregation and respiratory outcomes among urban black residents with and at risk of chronic obstructive pulmonary disease","volume":"204","author":"Woo","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ebiom.2026.106212_bib42","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2147\/COPD.S79077","article-title":"Defining and targeting health disparities in chronic obstructive pulmonary disease","volume":"11","author":"Pleasants","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ebiom.2026.106212_bib43","article-title":"Social determinants and indicators of COVID-19 among marginalized communities: a scientific review and call to action for pandemic response and recovery","volume":"17","author":"Brakefield","year":"2022","journal-title":"Disaster Med Public Health Prep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106212_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15347-4","article-title":"Incidence rate and risk factors of pulmonary conditions three years post COVID-19 in Bronx, New York: a retrospective cohort study","volume":"15","author":"Henry","year":"2025","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106212_bib45","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/cid\/ciaf345","article-title":"SARS-CoV-2 infection and the long-term risk of pneumonia in an urban population: an observational cohort study up to 46 months after infection","volume":"81","author":"Duong","year":"2026","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106212_bib46","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.jaip.2025.05.010","article-title":"Longer-term effects of sars-cov-2 infection on asthma exacerbation","volume":"13","author":"Duong","year":"2025","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:59:36Z","timestamp":1783972776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S2352396426000940"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106212","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term impact of SARS-CoV-2 on recurrent COPD exacerbations","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106212"}}